18.188.202.89
dgid:
enl:
npi:0
-Advertisement-
-Advertisement-
Home Modeling study observes extended durability of aflibercept 8 mg

Conference Roundup

Modeling study observes extended durability of aflibercept 8 mg

Watch Now
By rd360stg
Matching study assesses faricimab versus aflibercept in DME and AMD
By rd360stg
TRUCKEE study assesses real-world efficacy and safety of faricimab in neovascular AMD
By rd360stg
Dr. Micheletti talks about the state of interventional glaucoma
By rd360stg
DAVIO 2: Dr. Regillo outlines the findings of EYP-1901 versus aflibercept in wet AMD
-Advertisement-
-Advertisement-
-Advertisement-
By rd360stg
Early-onset cataracts in pediatric patients: indicators, surgical intervention, and challenges
By rd360stg
Dr. Radcliffe shares highlights from a session covering the business of glaucoma
By rd360stg
Cost-effectiveness analysis of treatment options for geographic atrophy
By rd360stg
Regenxbio reports promising data on gene therapy for bilateral wet AMD
-Advertisement-
-Advertisement-
-Advertisement-
By rd360stg
Drs. Radcliffe and Ristvedt discuss treatment of glaucoma with iDose TR
By rd360stg
Gene therapy demonstrates safety and efficacy in XLRP
By rd360stg
Dr. ElMallah presents 2-year results of study on IOP lowering with iDose TR
By rd360stg
Study finds higher mortality risk in patients with inherited retinal diseases
-Advertisement-
-Advertisement-
Videos
All
Modeling study observes extended durability of aflibercept 8 mg
30 Oct, 2024

Michael Stewart, MD, Professor and Chairman Emeritus of Ophthalmology at...

Matching study assesses faricimab versus aflibercept in DME and AMD
30 Oct, 2024
TRUCKEE study assesses real-world efficacy and safety of faricimab in neovascular AMD
30 Oct, 2024
-Advertisement-
-Advertisement-

Contact Info

Grandin Library Building
Six Leigh Street
Clinton, New Jersey 08809

+908-505-8899
[email protected]

Social Links

© 2024 Ophthalmology 360® is a trademark of International Healthcare Media, LLC. All rights Reserved
-Advertisement-
-Advertisement-